nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CACNA1F—retina—malignant glioma	0.024	0.0731	CbGeAlD
Nimodipine—Vasospasm—Carmustine—malignant glioma	0.0154	0.113	CcSEcCtD
Nimodipine—CACNB4—telencephalon—malignant glioma	0.0145	0.0442	CbGeAlD
Nimodipine—CACNB1—telencephalon—malignant glioma	0.0116	0.0353	CbGeAlD
Nimodipine—CACNB4—medulla oblongata—malignant glioma	0.0114	0.0348	CbGeAlD
Nimodipine—CACNB3—telencephalon—malignant glioma	0.0111	0.0339	CbGeAlD
Nimodipine—CACNB4—midbrain—malignant glioma	0.0104	0.0318	CbGeAlD
Nimodipine—CACNB4—spinal cord—malignant glioma	0.0102	0.031	CbGeAlD
Nimodipine—CACNB1—medulla oblongata—malignant glioma	0.00911	0.0278	CbGeAlD
Nimodipine—CACNB3—medulla oblongata—malignant glioma	0.00874	0.0266	CbGeAlD
Nimodipine—Deep vein thrombosis—Temozolomide—malignant glioma	0.00838	0.0612	CcSEcCtD
Nimodipine—CACNB1—midbrain—malignant glioma	0.00833	0.0254	CbGeAlD
Nimodipine—CACNB4—central nervous system—malignant glioma	0.00825	0.0251	CbGeAlD
Nimodipine—AHR—telencephalon—malignant glioma	0.00824	0.0251	CbGeAlD
Nimodipine—CACNB1—spinal cord—malignant glioma	0.00812	0.0248	CbGeAlD
Nimodipine—CACNB2—retina—malignant glioma	0.00812	0.0247	CbGeAlD
Nimodipine—CACNB4—cerebellum—malignant glioma	0.00807	0.0246	CbGeAlD
Nimodipine—CACNB3—midbrain—malignant glioma	0.00799	0.0243	CbGeAlD
Nimodipine—CACNB2—telencephalon—malignant glioma	0.00747	0.0228	CbGeAlD
Nimodipine—CACNB1—central nervous system—malignant glioma	0.00659	0.0201	CbGeAlD
Nimodipine—CACNB4—brain—malignant glioma	0.00655	0.02	CbGeAlD
Nimodipine—CACNA1D—telencephalon—malignant glioma	0.00653	0.0199	CbGeAlD
Nimodipine—AHR—medulla oblongata—malignant glioma	0.00647	0.0197	CbGeAlD
Nimodipine—CACNB1—cerebellum—malignant glioma	0.00644	0.0196	CbGeAlD
Nimodipine—CACNB3—central nervous system—malignant glioma	0.00632	0.0193	CbGeAlD
Nimodipine—NR3C2—brainstem—malignant glioma	0.00618	0.0188	CbGeAlD
Nimodipine—CACNB3—cerebellum—malignant glioma	0.00618	0.0188	CbGeAlD
Nimodipine—CACNA1C—telencephalon—malignant glioma	0.00603	0.0184	CbGeAlD
Nimodipine—NR3C2—retina—malignant glioma	0.00597	0.0182	CbGeAlD
Nimodipine—AHR—midbrain—malignant glioma	0.00592	0.018	CbGeAlD
Nimodipine—AHR—spinal cord—malignant glioma	0.00577	0.0176	CbGeAlD
Nimodipine—NR3C2—telencephalon—malignant glioma	0.00549	0.0167	CbGeAlD
Nimodipine—CACNB1—brain—malignant glioma	0.00523	0.0159	CbGeAlD
Nimodipine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.0051	0.0372	CcSEcCtD
Nimodipine—CACNB3—brain—malignant glioma	0.00502	0.0153	CbGeAlD
Nimodipine—AHR—cerebellum—malignant glioma	0.00458	0.0139	CbGeAlD
Nimodipine—Phlebitis—Carmustine—malignant glioma	0.00445	0.0325	CcSEcCtD
Nimodipine—NR3C2—medulla oblongata—malignant glioma	0.00431	0.0131	CbGeAlD
Nimodipine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00426	0.0311	CcSEcCtD
Nimodipine—CACNB2—central nervous system—malignant glioma	0.00425	0.0129	CbGeAlD
Nimodipine—CACNB2—cerebellum—malignant glioma	0.00415	0.0126	CbGeAlD
Nimodipine—NR3C2—midbrain—malignant glioma	0.00394	0.012	CbGeAlD
Nimodipine—Hyponatraemia—Carmustine—malignant glioma	0.00385	0.0281	CcSEcCtD
Nimodipine—NR3C2—spinal cord—malignant glioma	0.00384	0.0117	CbGeAlD
Nimodipine—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00383	0.028	CcSEcCtD
Nimodipine—AHR—brain—malignant glioma	0.00372	0.0113	CbGeAlD
Nimodipine—CACNA1D—central nervous system—malignant glioma	0.00371	0.0113	CbGeAlD
Nimodipine—CACNA1D—cerebellum—malignant glioma	0.00363	0.0111	CbGeAlD
Nimodipine—Liver function test abnormal—Carmustine—malignant glioma	0.00354	0.0258	CcSEcCtD
Nimodipine—CACNA1C—central nervous system—malignant glioma	0.00343	0.0104	CbGeAlD
Nimodipine—CACNB2—brain—malignant glioma	0.00337	0.0103	CbGeAlD
Nimodipine—CACNA1C—cerebellum—malignant glioma	0.00335	0.0102	CbGeAlD
Nimodipine—Clevidipine—BCHE—malignant glioma	0.00327	0.276	CrCbGaD
Nimodipine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00326	0.0238	CcSEcCtD
Nimodipine—NR3C2—central nervous system—malignant glioma	0.00312	0.0095	CbGeAlD
Nimodipine—Sweating increased—Temozolomide—malignant glioma	0.00312	0.0228	CcSEcCtD
Nimodipine—Amlodipine—CYP2B6—malignant glioma	0.0031	0.261	CrCbGaD
Nimodipine—NR3C2—cerebellum—malignant glioma	0.00305	0.00929	CbGeAlD
Nimodipine—CACNA1D—brain—malignant glioma	0.00295	0.00898	CbGeAlD
Nimodipine—Depression—Carmustine—malignant glioma	0.00294	0.0215	CcSEcCtD
Nimodipine—Depression—Temozolomide—malignant glioma	0.00284	0.0208	CcSEcCtD
Nimodipine—Nifedipine—CYP2B6—malignant glioma	0.00277	0.233	CrCbGaD
Nimodipine—Nicardipine—CYP2B6—malignant glioma	0.00273	0.23	CrCbGaD
Nimodipine—CACNA1C—brain—malignant glioma	0.00272	0.00829	CbGeAlD
Nimodipine—Hepatobiliary disease—Temozolomide—malignant glioma	0.0027	0.0197	CcSEcCtD
Nimodipine—Hepatitis—Temozolomide—malignant glioma	0.00256	0.0187	CcSEcCtD
Nimodipine—NR3C2—brain—malignant glioma	0.00248	0.00755	CbGeAlD
Nimodipine—Flushing—Carmustine—malignant glioma	0.00246	0.018	CcSEcCtD
Nimodipine—Flushing—Temozolomide—malignant glioma	0.00238	0.0174	CcSEcCtD
Nimodipine—Cardiac disorder—Temozolomide—malignant glioma	0.00238	0.0174	CcSEcCtD
Nimodipine—Angiopathy—Temozolomide—malignant glioma	0.00232	0.017	CcSEcCtD
Nimodipine—Immune system disorder—Temozolomide—malignant glioma	0.00231	0.0169	CcSEcCtD
Nimodipine—Anaemia—Carmustine—malignant glioma	0.00213	0.0156	CcSEcCtD
Nimodipine—Anaemia—Temozolomide—malignant glioma	0.00206	0.015	CcSEcCtD
Nimodipine—Hypertension—Carmustine—malignant glioma	0.00199	0.0145	CcSEcCtD
Nimodipine—Palpitations—Temozolomide—malignant glioma	0.00197	0.0144	CcSEcCtD
Nimodipine—Myalgia—Carmustine—malignant glioma	0.00196	0.0143	CcSEcCtD
Nimodipine—Hypertension—Temozolomide—malignant glioma	0.00192	0.0141	CcSEcCtD
Nimodipine—Myalgia—Temozolomide—malignant glioma	0.0019	0.0139	CcSEcCtD
Nimodipine—Oedema—Carmustine—malignant glioma	0.00188	0.0137	CcSEcCtD
Nimodipine—Thrombocytopenia—Carmustine—malignant glioma	0.00184	0.0135	CcSEcCtD
Nimodipine—Tachycardia—Carmustine—malignant glioma	0.00184	0.0134	CcSEcCtD
Nimodipine—Oedema—Temozolomide—malignant glioma	0.00182	0.0133	CcSEcCtD
Nimodipine—Nervous system disorder—Temozolomide—malignant glioma	0.00178	0.013	CcSEcCtD
Nimodipine—Thrombocytopenia—Temozolomide—malignant glioma	0.00178	0.013	CcSEcCtD
Nimodipine—Hypotension—Carmustine—malignant glioma	0.00176	0.0128	CcSEcCtD
Nimodipine—Hyperhidrosis—Temozolomide—malignant glioma	0.00176	0.0128	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00172	0.0125	CcSEcCtD
Nimodipine—Dyspnoea—Carmustine—malignant glioma	0.00168	0.0123	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00166	0.0121	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00163	0.0119	CcSEcCtD
Nimodipine—Dyspnoea—Temozolomide—malignant glioma	0.00162	0.0118	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00157	0.0115	CcSEcCtD
Nimodipine—Hypersensitivity—Carmustine—malignant glioma	0.00139	0.0101	CcSEcCtD
Nimodipine—Hypersensitivity—Temozolomide—malignant glioma	0.00134	0.00979	CcSEcCtD
Nimodipine—Diarrhoea—Carmustine—malignant glioma	0.00129	0.00941	CcSEcCtD
Nimodipine—Pruritus—Temozolomide—malignant glioma	0.00129	0.0094	CcSEcCtD
Nimodipine—CYP3A4—central nervous system—malignant glioma	0.00127	0.00386	CbGeAlD
Nimodipine—Dizziness—Carmustine—malignant glioma	0.00124	0.00909	CcSEcCtD
Nimodipine—Diarrhoea—Temozolomide—malignant glioma	0.00124	0.00909	CcSEcCtD
Nimodipine—Dizziness—Temozolomide—malignant glioma	0.0012	0.00879	CcSEcCtD
Nimodipine—Vomiting—Carmustine—malignant glioma	0.0012	0.00874	CcSEcCtD
Nimodipine—Rash—Carmustine—malignant glioma	0.00119	0.00867	CcSEcCtD
Nimodipine—Dermatitis—Carmustine—malignant glioma	0.00119	0.00866	CcSEcCtD
Nimodipine—Headache—Carmustine—malignant glioma	0.00118	0.00861	CcSEcCtD
Nimodipine—Vomiting—Temozolomide—malignant glioma	0.00116	0.00845	CcSEcCtD
Nimodipine—Rash—Temozolomide—malignant glioma	0.00115	0.00838	CcSEcCtD
Nimodipine—Dermatitis—Temozolomide—malignant glioma	0.00115	0.00837	CcSEcCtD
Nimodipine—Headache—Temozolomide—malignant glioma	0.00114	0.00832	CcSEcCtD
Nimodipine—Nausea—Carmustine—malignant glioma	0.00112	0.00817	CcSEcCtD
Nimodipine—Nausea—Temozolomide—malignant glioma	0.00108	0.00789	CcSEcCtD
Nimodipine—CACNB3—Axon guidance—KRAS—malignant glioma	0.000261	0.000498	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—FGFR1—malignant glioma	0.000257	0.000492	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PTK2—malignant glioma	0.000256	0.00049	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—PTPN11—malignant glioma	0.000256	0.000489	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—PTPN11—malignant glioma	0.000256	0.000489	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP2B6—malignant glioma	0.000254	0.000485	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—KRAS—malignant glioma	0.000253	0.000485	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HES1—malignant glioma	0.000252	0.000481	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—PPARG—malignant glioma	0.000251	0.000481	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NCOR1—malignant glioma	0.00025	0.000479	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—EGFR—malignant glioma	0.000246	0.000471	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—RAF1—malignant glioma	0.000246	0.00047	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—IDH1—malignant glioma	0.000245	0.000468	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—FGFR1—malignant glioma	0.000244	0.000466	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MMP9—malignant glioma	0.000244	0.000466	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MMP9—malignant glioma	0.000243	0.000465	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—ERBB2—malignant glioma	0.000243	0.000465	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KDR—malignant glioma	0.000242	0.000464	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—CDKN2B—malignant glioma	0.000238	0.000456	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT2—malignant glioma	0.000238	0.000456	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MET—malignant glioma	0.000237	0.000454	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—IDH2—malignant glioma	0.000237	0.000453	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SPHK1—malignant glioma	0.000237	0.000453	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MMP9—malignant glioma	0.000237	0.000453	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TNF—malignant glioma	0.000234	0.000448	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—RAF1—malignant glioma	0.000233	0.000445	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000233	0.000445	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—KRAS—malignant glioma	0.000233	0.000445	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP2C18—malignant glioma	0.000232	0.000444	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—IDH1—malignant glioma	0.000232	0.000444	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP2—malignant glioma	0.000231	0.000441	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP2—malignant glioma	0.000231	0.000441	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—ERBB2—malignant glioma	0.00023	0.00044	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KDR—malignant glioma	0.00023	0.000439	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000229	0.000439	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NOTCH1—malignant glioma	0.000228	0.000437	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NCOR1—malignant glioma	0.000226	0.000432	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MET—malignant glioma	0.000225	0.00043	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SPHK1—malignant glioma	0.000225	0.000429	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP2B6—malignant glioma	0.000223	0.000426	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP2C18—malignant glioma	0.00022	0.000421	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—PTPN11—malignant glioma	0.000219	0.00042	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—FGF2—malignant glioma	0.000219	0.000419	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—VEGFA—malignant glioma	0.000219	0.000418	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—VEGFA—malignant glioma	0.000218	0.000418	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—STAT3—malignant glioma	0.000217	0.000414	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NOTCH1—malignant glioma	0.000216	0.000414	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—PPARG—malignant glioma	0.000216	0.000412	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—FGFR1—malignant glioma	0.000214	0.00041	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTP1—malignant glioma	0.000213	0.000408	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—VEGFA—malignant glioma	0.000213	0.000407	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—STAT3—malignant glioma	0.000211	0.000403	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MMP9—malignant glioma	0.000208	0.000399	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—PTPN11—malignant glioma	0.000208	0.000397	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CAT—malignant glioma	0.000207	0.000397	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—RAF1—malignant glioma	0.000204	0.000391	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—RAF1—malignant glioma	0.000204	0.000391	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT2—malignant glioma	0.000204	0.000391	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—PPARG—malignant glioma	0.000204	0.00039	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—IDH1—malignant glioma	0.000204	0.00039	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—ERBB2—malignant glioma	0.000202	0.000387	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—ERBB2—malignant glioma	0.000202	0.000387	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KDR—malignant glioma	0.000202	0.000386	CbGpPWpGaD
Nimodipine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000201	0.000385	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP2—malignant glioma	0.000198	0.000378	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MET—malignant glioma	0.000197	0.000378	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MMP9—malignant glioma	0.000197	0.000377	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SPHK1—malignant glioma	0.000197	0.000377	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EGFR—malignant glioma	0.000197	0.000376	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—EGFR—malignant glioma	0.000197	0.000376	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—NCOR1—malignant glioma	0.000196	0.000374	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT2—malignant glioma	0.000194	0.00037	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP2C18—malignant glioma	0.000193	0.00037	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—MYC—malignant glioma	0.000192	0.000367	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EGFR—malignant glioma	0.000191	0.000366	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NOTCH1—malignant glioma	0.00019	0.000363	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000188	0.00036	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—FGF2—malignant glioma	0.000188	0.000359	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTT1—malignant glioma	0.000188	0.000359	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP2—malignant glioma	0.000187	0.000358	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TNF—malignant glioma	0.000187	0.000358	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VEGFA—malignant glioma	0.000187	0.000358	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—KRAS—malignant glioma	0.000186	0.000355	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—KRAS—malignant glioma	0.000186	0.000355	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PTPN11—malignant glioma	0.000183	0.000349	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TNF—malignant glioma	0.000182	0.000349	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—KRAS—malignant glioma	0.000181	0.000346	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PPARG—malignant glioma	0.000179	0.000343	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—FGF2—malignant glioma	0.000178	0.00034	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTT1—malignant glioma	0.000178	0.00034	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—malignant glioma	0.000177	0.000339	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000176	0.000337	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS1—malignant glioma	0.000176	0.000337	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—RAF1—malignant glioma	0.000175	0.000335	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—AKT1—malignant glioma	0.000175	0.000334	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP9—malignant glioma	0.000174	0.000332	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP9—malignant glioma	0.000173	0.000332	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ERBB2—malignant glioma	0.000173	0.000332	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NOTCH1—malignant glioma	0.000172	0.000328	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT2—malignant glioma	0.00017	0.000325	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—EGFR—malignant glioma	0.000168	0.000322	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS1—malignant glioma	0.000167	0.000319	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—RAF1—malignant glioma	0.000166	0.000317	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP2—malignant glioma	0.000165	0.000315	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ERBB2—malignant glioma	0.000164	0.000314	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—BCHE—malignant glioma	0.000164	0.000313	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—COX8A—malignant glioma	0.000163	0.000311	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PPARG—malignant glioma	0.000162	0.00031	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SLC5A5—malignant glioma	0.000162	0.000309	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CAV1—malignant glioma	0.00016	0.000305	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—EGFR—malignant glioma	0.00016	0.000305	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—KRAS—malignant glioma	0.000159	0.000304	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—FGF2—malignant glioma	0.000156	0.000299	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTT1—malignant glioma	0.000156	0.000299	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—malignant glioma	0.000156	0.000298	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—malignant glioma	0.000156	0.000298	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—BCHE—malignant glioma	0.000155	0.000296	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—STAT3—malignant glioma	0.000154	0.000295	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SLC5A5—malignant glioma	0.000153	0.000293	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—KRAS—malignant glioma	0.000151	0.000288	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP9—malignant glioma	0.000149	0.000284	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS1—malignant glioma	0.000146	0.00028	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—RAF1—malignant glioma	0.000146	0.000279	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CG—malignant glioma	0.000145	0.000278	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ERBB2—malignant glioma	0.000144	0.000276	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP9—malignant glioma	0.000141	0.000269	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PPARG—malignant glioma	0.00014	0.000268	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EGFR—malignant glioma	0.00014	0.000268	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—EGFR—malignant glioma	0.00014	0.000268	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—AKT1—malignant glioma	0.00014	0.000267	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ASMT—malignant glioma	0.000138	0.000265	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—BCHE—malignant glioma	0.000136	0.00026	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—AKT1—malignant glioma	0.000136	0.00026	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SLC5A5—malignant glioma	0.000134	0.000257	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—malignant glioma	0.000134	0.000255	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—malignant glioma	0.000134	0.000255	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—KRAS—malignant glioma	0.000132	0.000253	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—KRAS—malignant glioma	0.000132	0.000253	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—STAT3—malignant glioma	0.000132	0.000253	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000132	0.000252	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.00013	0.000249	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTP1—malignant glioma	0.00013	0.000249	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—BCAN—malignant glioma	0.00013	0.000249	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000129	0.000246	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CD—malignant glioma	0.000128	0.000244	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CAT—malignant glioma	0.000127	0.000242	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—malignant glioma	0.000127	0.000242	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—STAT3—malignant glioma	0.000125	0.00024	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP9—malignant glioma	0.000124	0.000237	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTP1—malignant glioma	0.000123	0.000236	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EGFR—malignant glioma	0.00012	0.00023	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CAT—malignant glioma	0.00012	0.000229	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NCOR1—malignant glioma	0.00012	0.000229	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—malignant glioma	0.000114	0.000219	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—malignant glioma	0.000114	0.000218	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KRAS—malignant glioma	0.000114	0.000217	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NCOR1—malignant glioma	0.000113	0.000217	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CB—malignant glioma	0.000111	0.000213	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—malignant glioma	0.000111	0.000213	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—malignant glioma	0.00011	0.000211	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—STAT3—malignant glioma	0.00011	0.00021	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—malignant glioma	0.000108	0.000207	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTP1—malignant glioma	0.000108	0.000207	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KRAS—malignant glioma	0.000108	0.000206	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CAT—malignant glioma	0.000105	0.000202	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—IDH2—malignant glioma	0.000105	0.000201	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—malignant glioma	0.0001	0.000191	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NCOR1—malignant glioma	9.96e-05	0.00019	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT1—malignant glioma	9.94e-05	0.00019	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP2B6—malignant glioma	9.87e-05	0.000189	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CAV1—malignant glioma	9.75e-05	0.000186	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTEN—malignant glioma	9.63e-05	0.000184	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—malignant glioma	9.53e-05	0.000182	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KRAS—malignant glioma	9.45e-05	0.000181	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—malignant glioma	9.24e-05	0.000177	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CAV1—malignant glioma	9.24e-05	0.000177	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—IDH1—malignant glioma	9.02e-05	0.000173	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CG—malignant glioma	8.88e-05	0.00017	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SPHK1—malignant glioma	8.73e-05	0.000167	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPARG—malignant glioma	8.57e-05	0.000164	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP2C18—malignant glioma	8.55e-05	0.000164	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT1—malignant glioma	8.52e-05	0.000163	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CG—malignant glioma	8.41e-05	0.000161	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPARG—malignant glioma	8.12e-05	0.000155	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CAV1—malignant glioma	8.12e-05	0.000155	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT1—malignant glioma	8.07e-05	0.000154	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CD—malignant glioma	7.81e-05	0.000149	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—COX8A—malignant glioma	7.57e-05	0.000145	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CD—malignant glioma	7.4e-05	0.000141	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CG—malignant glioma	7.39e-05	0.000141	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPARG—malignant glioma	7.13e-05	0.000136	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT1—malignant glioma	7.09e-05	0.000136	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTT1—malignant glioma	6.92e-05	0.000132	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CB—malignant glioma	6.81e-05	0.00013	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CA—malignant glioma	6.79e-05	0.00013	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—malignant glioma	6.75e-05	0.000129	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CD—malignant glioma	6.5e-05	0.000124	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS1—malignant glioma	6.48e-05	0.000124	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CB—malignant glioma	6.45e-05	0.000123	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ASMT—malignant glioma	6.44e-05	0.000123	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AKT1—malignant glioma	6.41e-05	0.000123	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—malignant glioma	6.39e-05	0.000122	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—BCAN—malignant glioma	6.05e-05	0.000116	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—BCHE—malignant glioma	6.03e-05	0.000115	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC5A5—malignant glioma	5.95e-05	0.000114	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTEN—malignant glioma	5.88e-05	0.000112	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CB—malignant glioma	5.66e-05	0.000108	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—malignant glioma	5.61e-05	0.000107	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTEN—malignant glioma	5.57e-05	0.000107	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKT1—malignant glioma	5.55e-05	0.000106	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTEN—malignant glioma	4.89e-05	9.36e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—IDH2—malignant glioma	4.88e-05	9.33e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTP1—malignant glioma	4.8e-05	9.17e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CAT—malignant glioma	4.67e-05	8.92e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.59e-05	8.77e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOR1—malignant glioma	4.41e-05	8.43e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—IDH1—malignant glioma	4.2e-05	8.02e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CA—malignant glioma	4.15e-05	7.93e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SPHK1—malignant glioma	4.06e-05	7.76e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.98e-05	7.6e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CA—malignant glioma	3.93e-05	7.51e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CAV1—malignant glioma	3.59e-05	6.87e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CA—malignant glioma	3.45e-05	6.6e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKT1—malignant glioma	3.39e-05	6.48e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CG—malignant glioma	3.27e-05	6.26e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTT1—malignant glioma	3.22e-05	6.15e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKT1—malignant glioma	3.21e-05	6.14e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARG—malignant glioma	3.16e-05	6.04e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS1—malignant glioma	3.01e-05	5.76e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CD—malignant glioma	2.88e-05	5.5e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKT1—malignant glioma	2.82e-05	5.39e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—BCHE—malignant glioma	2.8e-05	5.36e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.77e-05	5.29e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.51e-05	4.79e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—malignant glioma	2.48e-05	4.75e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTP1—malignant glioma	2.23e-05	4.26e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CAT—malignant glioma	2.17e-05	4.15e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTEN—malignant glioma	2.17e-05	4.14e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOR1—malignant glioma	2.05e-05	3.92e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CAV1—malignant glioma	1.67e-05	3.19e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.53e-05	2.92e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.52e-05	2.91e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARG—malignant glioma	1.47e-05	2.81e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.34e-05	2.56e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKT1—malignant glioma	1.25e-05	2.39e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.17e-05	2.23e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.16e-05	2.21e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTEN—malignant glioma	1.01e-05	1.93e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.11e-06	1.36e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKT1—malignant glioma	5.81e-06	1.11e-05	CbGpPWpGaD
